New injection aims to curb blood loss in common knee surgery
NCT ID NCT07127042
Summary
This study is testing whether a new drug called BT-114143 can safely reduce blood loss during and after knee replacement surgery. It will compare two different doses of the new drug against a standard medication (tranexamic acid) in 270 adults having the surgery. The main goal is to see if the new drug leads to less total blood loss, which could help patients recover better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL KNEE ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Orthopaedics, West China Hospital, SIchuan University
RECRUITINGChengdu, Si'Chuan, 37 Guoxuexiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.